P025 AI/Technology in Dermatology
DESCRIPTION
Explore the transformative potential of AI and technology in dermatology in this captivating session. Delve into cutting-edge innovations like AI-driven diagnostic tools, telemedicine, and digital skin mapping. Learn how machine learning algorithms enhance early detection and treatment of skin disorders while improving patient outcomes. Discover the ethical considerations and challenges in implementing AI-based solutions, and engage in discussions on the future of personalized skincare and the evolving role of dermatologists in the age of technology. Join us in shaping the future of skin health.
LEARNING OBJECTIVES
Assess the role and potential of AI-driven technologies in the field of dermatology: Participants will able to distinguish various ways artificial intelligence is being utilized in dermatology, including image analysis, diagnosis support, and treatment planning. They will also explore the potential benefits and challenges of AI integration in dermatological practice, such as improved accuracy, reduced diagnostic time, ethical considerations, and data privacy concerns.
Examine current applications and case studies of AI in dermatology: Participants will review existing AI-based tools and platforms used in the diagnosis and management of skin conditions, such as smartphone applications, teledermatology services, and computer-aided detection systems. They will analyze real-world case studies to understand the effectiveness of these technologies in clinical settings, and discuss the limitations and areas for improvement. Discuss Digital divide due to technology
SCHEDULE
4:00 PM
Introduction
Trilokraj Tejasvi, MD, MBBS
4:10 PM
AI updates in Cutaneous Imaging
Lilia M Correa, MD, FAAD
4:30 PM
AI in EMR and Tele pathology
Mahin Alamgir, MD, MBBS, FAAD
4:50 PM
AI in Dermatology: Bridging the health equity gap or deepening the digital divide?
Cory Simpson, MD, PhD, FAAD
5:25 PM
AI in Clinic: What’s Hype vs Happening Now
Ivy Lee, MD, FAAD
5:45 PM
Q&A and Panel discussion
SPEAKERS
Mahin Alamgir, MD, MBBS, FAAD
Lilia M Correa, MD, FAAD
University of South Florida / Moffitt Cancer Center
Ivy Lee, MD, FAAD
Cory Simpson, MD, PhD, FAAD
Department of Dermatology, University of Washington
Trilokraj Tejasvi, MD, MBBS
SPEAKER DISCLOSURES
Mahin Alamgir, MD, MBBS, FAAD
No financial relationships exist with ineligible companies.
Lilia M Correa, MD, FAAD
AccuTec Blades – Consultant(Honoraria); Castle Biosciences – Consultant(Honoraria); Enspectra Health – Consultant (1099 relationship)(Honoraria); La Roche Posay Dermatologique – Speaker(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding);
Ivy Lee, MD, FAAD
DIrect Dermatology – Stockholder(Stock Options);
Cory Simpson, MD, PhD, FAAD
argenx – Advisory Board(Fees); LEO Foundation – Investigator(Grants/Research Funding); Mitsubishi Tanabe Pharma Development America – Advisory Board(Fees); United Health Care – Employee(Salary), Employee(Stock Options);
Trilokraj Tejasvi, MD, MBBS
No financial relationships exist with ineligible companies.